The European Medicines Agency (EMA) has accepted to review Mylan’s marketing authorisation applications (MAA) for proposed biosimilar trastuzumab and proposed...
Read more
Merck, known as MSD outside the United States and Canada, announced that new and updated data from six abstracts investigating...
Read more
Use of Sanofi’s dengue vaccine, the world’s first approved shot against the mosquito-borne virus, is to be strictly limited due...
Read more
AstraZeneca today announced that the EMA has accepted a variation to the Marketing Authorisation Application (MAAv) for Tagrisso (osimertinib), a...
Read more
Novartis announced positive results from the FLASH study examining the safety and efficacy of directly switching chronic obstructive pulmonary disease...
Read more
GlaxoSmithKline plc and Innoviva, Inc. announced the filing of a supplemental New Drug Application (sNDA) with the US Food and...
Read more
Natural killer (NK) cells are lymphocytes of the innate immune system and are important in controlling tumors and infections without...
Read more
Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced a new licensing agreement...
Read more
Aldevron, a leading global provider of contract plasmid DNA manufacturing, protein production and antibody discovery services, announces the availability of...
Read more
Takeda Pharmaceutical Company Limit announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
